The role of interleukin-17 in asthma: a protective response?

While there now exist effective treatments for type 2 high, eosinophilic asthma, there are no specific therapies for 40–50% of people with asthma with other phenotypes, which result from poorly understood underlying pathological mechanisms. One such pathology is neutrophilic inflammation, which has...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Hynes, G, Hinks, T
Formáid: Journal article
Teanga:English
Foilsithe / Cruthaithe: European Respiratory Society 2020

Míreanna comhchosúla